Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Prevention of Ischemic Hepatitis Post Upper GI Bleed
NCT02015403Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Dec 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of acetylcysteine in Ischemic hepatitis (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Incidence of ischemic hepatitis at Day 5. Started Dec 2013; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Ischemic hepatitis
Beyond the preview
Go deeper on NCT02015403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015403.